Prohibitin: a potential target for new therapeutics
- 作者Suresh Mishra; Leigh C. Murphy; B.L. Gregoire Nyomba; Liam J. Murphy
- 卷第11卷
- 期第4期
- 印刷ISSN1471-4914
- 文件大小1989.08KB
- 发表时间2005
- DOI10.1016/j.molmed.2005.02.004
Tumors sweeten macrophages with acidsSekine, Hiroki; Yamamoto, Masayuki; Motohashi, Hozumi · Nature Immunology · 2018
Carcinogenesis and transcriptional regulation through Maf recognition elementsHozumi Motohashi; Masayuki Yamamoto · 2007
Solution structure of the DNA-binding domain of MafGKusunoki, Hideki; Motohashi, Hozumi; Katsuoka, Fumiki; Morohashi, Akio; Yamamoto, Masayuki; Tanaka, Toshiyuki · 2002
Toward clinical application of the Keap1–Nrf2 pathwaySuzuki, Takafumi; Motohashi, Hozumi; Yamamoto, Masayuki · Trends in Pharmacological Sciences · 2013
Alcohol dehydrogenase 3 contributes to the protection of liver from nonalcoholic steatohepatitisGoto, Maki; Kitamura, Hiroshi; Alam, Md. Morshedul; Ota, Nao; Haseba, Takeshi; Akimoto, Toshio; Shimizu, Akio; Takano-Yamamoto, Teruko; Yamamoto, Masayuki; Motohashi, Hozumi · Genes to Cells · 2015
Identification of polymorphisms in the promoter region of the human NRF2 geneTae Yamamoto; Keigyou Yoh; Akira Kobayashi; Yukio Ishii; Shigeo Kure; Akio Koyama; Tohru Sakamoto; Kiyohisa Sekizawa; Hozumi Motohashi; Masayuki Yamamoto · 2004
A stress-responsive transcriptional factor NRF2 activates hematopoietic stem cellsMurakami, Shohei; Yamamoto, Masayuki; Motohashi, Hozumi · Experimental Hematology · 2015